COMMUNIQUÉS West-GlobeNewswire

Histogenics and FDA Conclude Discussions Regarding NeoCart® Phase 3 Clinical Trial Data and Regulatory Pathway
21/12/2018
‒ Histogenics to Discontinue Development of NeoCart and Explore Strategic Alternatives ‒ WALTHAM, Mass., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), today provided an update [...]
Galapagos to Present at 37th Annual J.P. Morgan Healthcare Conference
21/12/2018
Mechelen, Belgium; 21 December 2018, 22.01 CET - Galapagos NV (Euronext & NASDAQ: GLPG) will participate in the 37th Annual J.P. Morgan Healthcare Conference on January 8 & 9, 2019. Onno van de Stolpe, CEO, will [...]
Ascendis Pharma A/S Announces Participation in 37th Annual J.P. Morgan Healthcare Conference
21/12/2018
COPENHAGEN, Denmark, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon ™ technology to address significant unmet medical needs, today [...]
Bavarian Nordic Announces FDA Acceptance and Priority Review of Biologics License Application for MVA-BN Smallpox Vaccine
21/12/2018
COPENHAGEN, Denmark, December 21, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced that the U.S. Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for the liquid- [...]
Bonify Selects RavenQuest to Provide Management Services
21/12/2018
VANCOUVER, British Columbia, Dec. 21, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB, OTCQB: RVVQF, Frankfurt: 1IT) announces it has been retained by Canadian Licensed [...]
Dentsply Sirona to Present at the 37th Annual J.P. Morgan Healthcare Conference
21/12/2018
YORK, Pa., Dec. 21, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq:XRAY), The Dental Solutions Company, today announced it will participate in the 37 th Annual J.P. Morgan Healthcare [...]
GBT Appoints Dawn Svoronos to Board of Directors
21/12/2018
SOUTH SAN FRANCISCO, Calif., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced the appointment of Dawn Svoronos to the company’s board of directors. Ms. Svoronos has [...]
Fortress Biotech Recaps Corporate Highlights and Achievements in 2018
21/12/2018
NEW YORK, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference
21/12/2018
THE WOODLANDS, Texas, Dec. 21, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Lonnel Coats, President and Chief Executive Officer, will present at the following conference: 37 [...]
Rubius Therapeutics, Inc. Secures $75 Million Loan Facility
21/12/2018
CAMBRIDGE, Mass., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a biotechnology company developing an entirely new class of allogeneic cellular therapies, today announced it has entered [...]
Spineway : International Symposium in Peru
21/12/2018
Press release Ecully, 20 December 2018 SPINEWAY International Symposium in Peru Spineway presents its Mont Blanc and Kili product lines Spineway, specialist in surgical implants and instruments for treating disorders of [...]
SPINEWAY : Symposium international au Pérou
21/12/2018
Communiqué de presse Ecully, le 21 décembre 2018 SPINEWAY Symposium international au Pérou Spineway présente ses gammes Mont-Blanc et Kili Spineway, spécialiste des implants et ancillaires chirurgicaux pour le [...]
Merus annonce un règlement global et la fin de tous les litiges en matière de brevets avec Regeneron Pharmaceuticals
21/12/2018
Merus et Regeneron accordent des licences croisées pour des brevets portant sur certaines technologies de plateforme de génération d'anticorps Regeneron achètera 15 millions de dollars d’actions ordinaires de Merus [...]
VALNEVA Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate
21/12/2018
Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate Saint-Herblain (France), December 21, 2018 - Valneva SE ("Valneva"), a biotech company developing and commercializing vaccines for infectious [...]
VALNEVA reçoit le statut de "Fast Track" de la FDA pour son candidat vaccin contre le Chikungunya
21/12/2018
Valneva reçoit le statut de "Fast Track" de la FDA pour son candidat vaccin contre le Chikungunya Saint-Herblain (France), 21 décembre 2018 -Valneva SE ("Valneva" ou "le Groupe"), société de biotechnologie développant [...]
Merger between Eckert & Ziegler BEBIG SA and Eckert & Ziegler Strahlen- und Medizintechnik AG - Announcement of the approval of the merger by the Extraordinary General Shareholders' Meeting of BEBIG.
21/12/2018
Press release REGULATED INFORMATION Seneffe, Belgium, December 21, 2018. Shareholders' general meeting The EGM of BEBIG approved on 21 December 2018 (i) the modification of the financial year of BEBIG and (ii) the cross [...]
Fusion entre Eckert & Ziegler BEBIG SA (BEBIG) et Eckert & Ziegler Strahlen- und Medizintechnik AG (EZAG) - Annonce de l'approbation de la fusion par l'assemblée générale extraordinaire de BEBIG.
21/12/2018
Communiqué de presse Information reglementée Seneffe, Belgique, 21 décembre 2018. Assemblée générale des actionnaires L'AGE de BEBIG a approuvé le 21 décembre 2018 (i) la modification de l'exercice social de BEBIG et ( [...]
Director Declaration
21/12/2018
Director Declaration December 21, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announces that Ian Clark, Non-Executive Director of the Company, is a Non-Executive Director of Guardant Health, Inc which [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
21/12/2018
FIT Biotech Oy Company release December 21, 2018 at 05:00 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]

Pages